LEXICON PHARMACEUTICALS, INC.·4

Feb 29, 4:27 PM ET

Crum Brian T 4

4 · LEXICON PHARMACEUTICALS, INC. · Filed Feb 29, 2024

Insider Transaction Report

Form 4
Period: 2024-02-28
Crum Brian T
SVP, General Counsel & Secr.
Transactions
  • Exercise/Conversion

    Common Stock

    2024-02-28+33,457203,101 total
  • Exercise/Conversion

    Common Stock

    2024-02-28+8,750143,548 total
  • Exercise/Conversion

    Common Stock

    2024-02-28+26,096169,644 total
  • Tax Payment

    Common Stock

    2024-02-28$2.62/sh25,604$67,082177,497 total
  • Exercise/Conversion

    Restricted Stock Units

    2024-02-288,7500 total
    Common Stock (8,750 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2024-02-2826,09626,097 total
    Common Stock (26,096 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2024-02-2833,45766,913 total
    Common Stock (33,457 underlying)
Footnotes (3)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of common stock.
  • [F2]Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.
  • [F3]Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT